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Background/aim: Ischemia on the colon wall negatively affects healing of anastomosis. We were aimed to evaluate the effects of carbon
monoxide releasing molecule-2 (CORM-2) on the healing of anastomosis in a rat model of the ischemic colon.
Materials and methods: In this prospective study a total of 60 rats were randomly divided into three groups as colon transection and
end-to-end anastomosis (Group I), colon transection, and end-to-end anastomosis following the induction of ischemia (Group II), and
colon transection and end-to-end anastomosis following the induction of ischemia and treated with daily intraperitoneal administration
of CORM-2 (Group III). Each group was also divided into two equal subgroups as postoperative 3rd and 7th day. Postoperative healing
of anastomoses was evaluated by anastomosis burst pressure (ABP), tissue biomarkers including hydroxyproline (HP), malondialdehyde
(MDA), glutathione (GSH), and histopathological findings.
Results: In the ischemic group treated with CORM-2, lower MDA and higher HP levels were observed in comparison to the untreated
ischemic group on the 3rd day. GSH and HP levels were higher and MDA levels was lower in the ischemic rats treated with CORM-2
than in the ischemic untreated rats on the 7th day. In the ischemic group treated with CORM-2, the mucosal epithelial score decreased
and the neoangiogenesis score increased compared to the untreated rats on the 7th day.
Conclusion: In ischemic colon anastomosis, reduces cell destruction by suppressing the oxidative reaction, and strengthening the
antioxidative mechanisms of the cells. It also increases collagen formation, epithelial development, and neoangiogenesis.
Key words: Anastomotic leak, angiogenesis, necrosis, ischemia, carbon monoxide releasing molecule-2 (CORM-2)

1. Introduction
Gastrointestinal (GI) anastomosis procedure is frequently
performed both as emergency cases and elective surgery.
Bacteria-laden intestinal content may spread into the
intraabdominal zone thus causing complications such as
intra-abdominal abscess, sepsis, and multiple organ failure
that may lead to death unless the anastomosis is sufficient
[1,2].
The strategic decision of surgical anastomosis
technique dependes on many factors such as comorbid
diseases, anastomosis tension, peritonitis, sepsis, and
ischemia. The latter is one of the important factors affecting
the healing process [3]. Ischemia in the anastomosis may

occur due to arteriosclerotic vascular disease, advanced
age, inflammatory vascular disease, vasoconstrictor drug
use, and vascular network damage during the surgical
manipulation [4,5].
During the GI anastomosis, the initial goal is to
achieve vasoconstriction for hemostasis. Following this
stage, insoluble hemostatic matrix structure consisting of
neutrophils, macrophages, and thrombocytes is formed
in the incision area by means of inflammatory mediators
[6,7].
In case of ischemia in the GI anastomosis, the
inflammatory agents and radical oxygen metabolites
(ROM) surge with the increase of cytokines, adhesive and
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vasoactive molecules during the healing process [8]. ROM
modifies the pH of the environment, causing break down
of the organelles and cell death [9]. In addition, the severity
of inflammatory reaction disrupts the balance between
synthesis and degradation of collagen by preventing
collagen synthesis and leads to anastomotic failure [10].
Motterlini et al. [11] stated that CORM-2 has a
vasodilator, antiischemic, and antiinflammatory effect in
both in vivo and in vitro environments. In a rat models
with ischemia/reperfusion damage of the small intestine,
CORM-2 has been shown to reduce the damage via
antioxidant, antiinflammatory, and antiapoptotic effects
[12]. Ahanger et al. [13] found that CORM-2 suppresses
the formation of proinflammatory adhesion molecules
and increases the release of antiinflammatory cytokines,
collagen production, and neovascularization in the skin
full-thickness wound model.
In this study, for the first time in the literature, we
aimed to evaluate the effect of CORM-2 on healing of
colon anastomosis by (i) analyzing the oxidative stress
through tissue malondialdehyde (MDA) and glutathione
(GSH) levels, (ii) evaluating the histological necrosis rate
and healing stages by histopathological examination, and
(iii) determining the healing degree of anastomosis by
measuring tissue hydroxyproline (HP) and anastomosis
burst pressure (ABP) in experimental ischemia-induced
colon anastomosis model.

2. Materials and methods
2.1. Ethical considerations and experimental design
This prospective experimental study was conducted at
Ankara University, Laboratory of Experimental Animals
after the approval of the Ethics Committee of Ankara
University, Experimental Animals (Approval Date:
09.05.2012; no.: 2012-10-70).
A total of 60 female Wistar albino rats weighing
between 180–220 g were kept in a specialized shelter
(The rats were fed with standard chow and tap water ad
libitum and lived at 12:12 h light-dark cycle with room 13
temperature at 21 °C as standard animal care condition)
and were healthy during the preoperative period. All rats
were randomly and equally divided into Group I (n = 20),
Group II (n = 20), and Group III (n = 20), and underwent
surgical procedures described below. The research design
is shown in Figure 1.
2.2. Surgical procedure and applications
Following anesthesia with intraperitoneal xylasine (5 mg/
kg) + ketamine (50 mg/kg), the procedures described
below accompanying laparotomy were performed.
Group I (transection/anastomosis): The colon
was dissected completely 3 cm proximal to the pelvic
peritoneum. The abdomen was closed after end-to-end
anastomosis of intestinal edges with 8 primary sutures
to make a single layer by using 6/0 polypropylene. Group
II (ischemia + transection/anastomosis): The incision

Figure 1. Research design. n: Number of rats; CORM-2: carbon monoxide releasing molecule-2; PMNL:
polymorphonuclear leukocyte; SBM-MS: bridging between submucosal and muscular layers.
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site of the colon was determined 3 cm proximal to pelvic
peritoneum. To achieve ischemia in the anastomosis line
2 cm proximal and 2 cm distal of mesenteric vessels (vasa
recta) were ligated. The abdomen was closed after end-toend anastomosis of intestinal edges with 8 primary sutures
to make a single layer by using 6/0 polypropylene. Group
III (ischemia + transection/anastomosis + CORM-2): the
same surgical procedure was implied as in Group II.
The operated rats were placed in seperate sections from
other rats and daily wound care was performed. They were
checked every 15–20 min and followed up by providing
liquid and food support.
In the postoperative period (including the day of
operation), intraperitoneal saline was given to Group I (n
= 20) and Group 2 (n = 20) once daily and intraperitoneal
CORM-2 (dissolved in 0.75% dimethyl sulfoxide prepared
with saline 5 mg/kg) was given to Group III (n = 20) until
the rats were sacrificed. Each group was also divided into
two equal subgroups (n = 10) according to the days of
sacrification on day 3 and 7.
All rats underwent re-laparotomy following anesthesia
with intraperitoneal xylasine (5 mg/kg) + ketamine (50 mg/
kg) on days 3 and 7. The abdominal incision was re-opened
and the colonic anastomosis was identified. The rats were
sacrificed following the resection of the colon segment
containing 3 cm proximal and distal to anastomosis
line. The dense omentum and bowel adhesions were not
separated from the anastomosis to preserve the integrity
of the anastomosis. The lumen was cleaned with saline.
Subsequently, the anastomotic segment was connected
to an infusion pump (Braun, Germany) on one side and
to a manometer (Datex-Ohmeda Compact S/5, Finland)
on the opposite side. The pressure was then raised by a
NaCl 0.9% solution was infused at a constant rate of 1 mL/
min. Anastomotic bursting pressure (ABP) was indicated
as a sudden loss of pressure and defined as the maximum
intraluminal pressure prior to leakage.
The resected segment was opened longitudinaly and
divided into three equal parts after the removal of 0.5 cm
proximal and distal anastomosis sections. The first piece
was placed in 10% formaldehyde for histopathological
examination. The other two parts were frozen at –40 oC
with liquid nitrogen for the measurement of HP, MDA,
and GSH levels.
2.3. Biochemical analyses
2.3.1. Hydroxyproline (HP) analysis
After addition of 6N hydrochloric acid (HCl) onto 0.1 g
of colon tissue that were weighed and transferred to the
Pyrex tubes, they were hydrolyzed at 105 oC for 18 h. 25 mL
of samples of hydrolysates were lyophilized and dissolved
in 1.2 mL of 50% (v/v) isopropyl alcohol. Chloramine T
solution was added to these samples and after 10-min
incubation, 1 mL Ehrlich reagent was added and the
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samples were incubated at 50 oC for 90 min. The color was
analyzed on a spectrophotometer at a wavelength of 560
nm. Under the same experimental conditions, 0.4, 0.6,
0.8, 1.2, and 1.6 µg HP standards were also analyzed and
sample concentrations were calculated from the standard
curve. The results were given as g HP/g tissue [14].
2.3.2. Malondialdehyde (MDA) analysis
Colon tissues were homogenized in 1.15% potassium
chloride (KCl) solution at a ratio of 1:10, and MDA levels
were analyzed with spectrophotometry from homogenate
by the thiobarbituric acid method. The results were
determined as nanomole (nmol) MDA per g of tissue [15].
2.3.3. Glutathione (GSH) analysis
GSH levels were measured via the Ellman method. The
tissues were homogenized with metaphosphoric acid and
centrifuged at 2500 rpm. The supernatant was colored
with dithionitrobenzoic acid and spectrophotometric
measurement was performed. Protein levels were also
analyzed using the same supernatant by the Lowry method
and results were reported as micromole (µmol) GSH per
mg tissue protein [16].
2.4. Histological analyses
The tissues for histopathological examination were
fixed in 10% formalin solution. Samples were taken
from anastomosis line and embedded in paraffin blocks.
Sections of 5 μm thickness were prepared from the blocks,
and routine hematoxylin-eosin staining was performed.
Histopathological examination was blindly reviewed
according to the modified Verhofstad/Ehrlich–Hunt
scoring system by a single pathologist (Table 1), [17–19].
2.5. Statistical analysis
Statistical analysis was performed using the SPSS v. 22.0
software (IBM Corp., Armonk, NY, USA). Power and
sample size were calculated by using G* Power version
3.1.9.2. Based on similar reference studies, partial etasquared values were set at 0.25 for Analysis of Variance
(ANOVA). Partial eta-squared values for three groups
was 0.25 and α = 0.05. The number of rats to reach power
level of 80% in each group was 27. Due to the possibility
of some rats dying, additional rats were included into each
group. Therefore, a total of 60 rats (30 for 3rd day and 30
for 7th day) were included in the study.
According to the outcomes of this study sufficient
number of sample size has been achieved for
malondialdehyde measurement (main purpose of our
study) as 99% for the group in which rats were sacrificed
on the 3rd day (n1 = 10, n2 = 10, n3 = 10). The group in
which rats were sacrificed on the 7th day, the partial etasquared value was 0.362 with the power of 93%. Normal
distribution fitness of the data was evaluated using the
Shapiro–Wilk test and variance homogeneity using the
Levene test. In the inter-group analysis, one-way analysis
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of variance (ANOVA) test was utilized for parametric tests
to compare the quantitative data of more than two groups,
while the Fisher’s least significant difference (LSD) and
Games–Howell tests were used for post-hoc analysis.
The Kruskal–Wallis test and Monte Carlo simulation
were used to analyze nonparametric variables. The posthoc analysis was carried out using Dunn’s test. Quantitative
variables were expressed in mean ± standard deviation
(SD), and median range (min-max), while categorical
variables were expressed in n (%). A p value of < 0.05 was
considered statistically significant with a 95% confidence
interval (CI).

3. Results
3.1. Anastomotic burst pressure (ABP)
There was no significant difference in the mean ABP values
on the 3rd day among the groups (p = 0.068) (Table 2). On
day 7, ABP of group I was higher than group II and III (p =
0.039 and p = 0.045, respectively). However, there was no
statistically significant difference between Groups II and
III (p = 0.769) (Table 3).
3.2. Biochemical findings
The HP levels of group I and III on 3rd and 7th days
were higher than those of group II (p < 0.001, p < 0.001

Table 1. Histopathological scoring system of modified Verhofstad/Ehrlich–Hunt.
Score

0

1

2

3

Necrosis

None

Little

Marked

Massive increased

PMNL

In normal count

Slight increase

Marked infiltration

Massive increased

MNL

In normal count

Slight increase

Marked infiltration

Massive increased

Edema

None

Slight increase

Marked

Massive increased

Mucosal epithelium

Normal glandular

Normal cubic

Missing cubic

None

Submucosal muscular layer

Good bridging

Moderate bridging

Weak bridging

No bridging

Granulation

None

Partial

Marked

Severe

Neoangiogenesis

None

Partial

Moderate

Marked

Fibroblast

None

Partial

Moderate

Marked

Collagen deposition

None

Partial

Moderate

Marked

PMNL: polymorphonuclear leukocyte; MNL: mononuclear leukocyte.

Table 2: Distribution of values of ABP, HP, GSH, and MDA on the day 3.

3rd day

ABP

HP

GSH (x103)

MDA

Group

Median
(Min-Max)

Mean ± SD

Mean ± SD

Median
(Min-Max)

I

9 (0–23)

426.30 ± 36.04

9.90 ± 1.20

86 (72–149)

II

4 (0–27)

325.60 ± 66.49

10.70 ± 1.16

180 (109–235)

III

15.5 (2–97)

443.44 ± 30.87

9.60 ± 0.84

79.5 (73–103)

0.068

<0.001

0.080

<0.001

I→II

NS

<0.001

NS

0.003

I→III

NS

0.441

NS

1

II→III

NS

<0.001

NS

<0.001

P-value
Pairwise
comparison

One-way ANOVA test, Post Hoc test: Fisher’s least significant difference (LSD-Games Howell; Kruskal–Wallis
test (Monte Carlo), Post Hoc test: Dunn’s test; NS: not significant; SD: standard deviation; Max: maximum; Min:
minimum.
ABP: anastomosis burst pressure; HP: hydroxyproline; GSH: glutathione; MDA: malondialdehyde.
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for the 3rd day, respectively) (p = 0.023, p = 0.040 for the
7th day, respectively). However, there was no statistically
significant difference in the HP levels of groups I and III (p
= 0.441 and p = 0.798, respectively) (Tables 2 and 3).
There was no significant difference in the GSH levels
on day 3 among the groups (p = 0.080) (Table 2). However,
the GSH levels in groups I and III were higher than group
II on the day 7 (p = 0.011 and p = 0.042, respectively),
although there was no significant difference between
group I and III (p = 0.518) (Table 3).
On the 3rd and 7th days, the MDA levels were higher
in group II than in groups I and III (p = 0.003 and p <
0.001 for the 3rd day, respectively) (p = 0.002 and p =
0.003 for the 7th day, respectively). However, there was no

significant difference in the MDA levels of groups I and III
(p = 1) (p = 0.817) (Tables 2 and 3).
3.3. Histopathological findings
On day 3, the necrosis rates of groups II and III were higher
than those of group I (p < 0.001 and p < 0.015, respectively),
although there was no statistically significant difference in
the necrosis rates between groups II and III (p = 0.586)
(Table 4). On day 7, the necrosis rates of group I was lower
than those of group II (p < 0.001), but not significantly
different from group III (p = 0.080). Although the necrosis
rates of group III tended to decrease compared to group II,
there was no statistically significant difference among the
groups (p = 0.292) (Table 5) (Figures 2a and 2b).

Table 3: Distribution of values of ABP, HP, GSH, and MDA on the day 7.

7th day

ABP

HP

GSH (x103)

MDA

Group

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

I

168.90 ± 37.35

349.70 ± 55.30

15.89 ± 2.47

64.89 ± 16.00

II

87.90 ± 83.88

287.33 ± 75.73

12.60 ± 2.95

95.50 ± 23.17

III

110.50 ± 58.95

343.20 ± 31.90

15.10 ± 2.38

67.00 ± 18.86

0.033

0.047

0.027

0.003

I→II

0.039

0.023

0.011

0.002

I→III

0.045

0.798

0.518

0.817

II→III

0.769

0.040

0.042

0.003

P value
Pairwise comparison

One-Way ANOVA test, Post Hoc test: Fisher’s least significant difference (LSD)-Games Howell; SD: standard deviation.
ABP: anastomosis burst pressure; HP: hydroxyproline; GSH: glutathione; MDA: malondialdehyde.
Table 4. Histopathological findings of each groups on day 3.
I

II

III

Pairwise comparison

3rd day

Median
(Min-Max)

Median
(Min-Max)

Median
(Min-Max)

P value

Necrosis

1 (0–2)

3 (2–3)

2 (2–3)

PMNL

2 (1–2)

2 (2–3)

3 (2–3)

MNL

1 (1–1)

1 (1–2)

Edema

1 (0–2)

1 (0–2)

Mucosal epithelium

2 (1–2)

Submucosal muscular layer

2 (2–3)

Granulation
Neoangio genesis

I→II

I→III

II→III

<0.001

<0.001

0.015

0.586

0.006

0.027

0.008

1

1 (1–1)

0.315

NS

NS

NS

0.5 (0–2)

0.332

NS

NS

NS.

3 (2–3)

2.5 (2–3)

0.004

0.010

0.034

1

3 (2–3)

3 (2–3)

0.010

0.008

0.035

1

1 (1–3)

1 (1–2)

1 (0–2)

0.471

NS

NS

NS

1 (1–2)

1 (1–2)

1 (1–2)

0.642

NS

NS

NS

Fibroblast

1 (1–3)

1 (1–2)

1 (1–2)

0.917

NS

NS

NS

Collagen deposition

0 (0–1)

0 (0–1)

0 (0–1)

0.509

NS

NS

NS

Kruskal–Wallis test (Monte Carlo), Post Hoc test: Dunn’s test; NS: Not significant; Max: maximum; Min: minimum
PMNL: polymorphonuclear leukocyte; MNL: mononuclear leukocyte
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Table 5: Histopathological findings of each group on day 7.
I

II

III

Pairwise comparison

7th day

Median
(Min-Max)

Median
(Min-Max)

Median
(Min-Max)

P Value

Necrosis

0 (0–1)

2 (1–3)

1 (0–2)

PMNL

2 (1–2)

2.5 (2–3)

MNL

1 (1–2)

2 (1–2)

Edema

1 (0–2)

Mucosal epithelium

2 (1–3)

Submucosal muscular layer

I→II

I→III

II→III

<0.001

<0.001

0.080

0.292

3 (2–3)

0.002

0.019

0.006

1

1 (0–2)

0.066

NS.

NS.

NS.

1 (0–2)

1 (0–2)

0.668

NS.

NS.

NS.

3 (2–3)

2 (1–3)

0.010

0.016

1

0.047

3 (2–3)

3 (2–3)

3 (2–3)

0.845

NS.

NS.

NS.

Granulation

2 (1–3)

2.5 (2–3)

2 (1–3)

0.219

NS.

NS.

NS.

Neoangio genesis

1.2 (1–2)

1.7 (1–2)

2.5 (2–3)

<0.001

0.207

<0.001

0.031

Fibroblast

2 (1–3)

3 (2–3)

3 (1–3)

0.027

0.027

0.017

1

Collagen deposition

1 (0–2)

1 (1–2)

1 (0–2)

0.736

NS

NS

NS

Kruskal–Wallis test (Monte Carlo), Post Hoc test: Dunn’s test; NS: not significant; Max: maximum; Min: minimum.
PMNL: polymorphonuclear leukocyte; MNL: mononuclear leukocyte.

Figure 2a. Microscopic appearance of the tissue on the 7th day in
group III, lower necrosis (4x10, H&E).

Figure 2b. Microscopic appearance of the tissue on the 7th day in
Group II, higher necrosis (4x10, H&E).

The PMNL infiltration rates were higher in groups II
and III than those of group I on the 3rd and 7th days (p
= 0.027 and p = 0.008 for the 3rd day, respectively) (p =
0.019 and p = 0.006 for 7th day, respectively). However, the
PMNL infiltration rates were similar in group II and III (p
= 1.00) (Tables 4 and 5).
On day 3, the development rates of mucosal epithelium
in group II and III were lower than group I (p < 0.010,
p < 0.034, respectively). The rates of mucosal epithelium
development in group II and III were similar (p = 1.00)
(Table 4). On day 7, the development rates of mucosal
epithelium in group II were lower than those of groups I
and III (p = 0.016 and p = 0.047, respectively). There was no

significant difference in the development rates of mucosal
epithelium between groups I and III (p = 1) (Table 5).
On day 3, the rates of bridging between SBM and MS
layers in groups II and III were lower than those of group
I (p = 0.008 and p = 0.035, respectively). There was no
significant difference between groups II and III in terms
of bridging rates between SBM and MS layers (p = 1.00)
(Table 4). On day 7, there was no difference among the
groups in terms of bridging rates between SBM and MS
layers (p = 0.845) (Table 5).
On day 3, the development rates of fibroblasts in all
three groups were similar (p = 0.917) (Table 4). On day
7, the development rates of fibroblasts in groups II and III
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were higher than those of group I (p = 0.027 and p = 0.017,
respectively). However, there was no difference between
groups II and III (p = 1.00) (Table 5).
On day 3, the rates of neoangiogenesis development
were similar among all groups (p = 0.642) (Table 5). On
day 7, the rates of neoangiogenesis development were
higher in group III compared to groups I and II (p < 0.001
and p = 0.031, respectively) (Figures 3a and 3b). However,
there was no statistically significant difference between
Group I and II in terms of neoangiogenesis development
rate (p = 0.207) (Table 5).
On the 3rd and 7th days, there was no significant
difference among the groups in terms of edema (p = 0.315
and p = 0.668, respectively), granulation (p = 0.471 and p
= 0.219, respectively), and collagen deposition (p = 0.509
and p = 0.736, respectively).
4. Discussion
GI anastomosis healing is a systematic complex process of
a certain time interval. Disruption in one of these stages via
prolonged or excessive presence of cells in the anastomosis
repair causes anastomotic failure by interfering with the
entire healing process [20,21].
Ischemic damage deteriorates the healing process
by causing proinflammatory cytokines to dominate the
inflammatory phase of healing [22]. This study indicated
the importance of systemic application of CORM-2 on
colon anastomosis healing by decreasing cell destruction
caused by ischemic damage and increasing collagen
formation and neoangiogenesis. Cell destruction and
elevated MDA levels occur as a result of the peroxidation of
increased ROMs with unsaturated fats in cell membranes
as the severity of inflammation increases in ischemic tissue
[8,23,24].

In this study, PMNL infiltration and necrosis in the
histopathological evaluation and MDA values in the
biochemical evaluation were significantly higher in
the ischemic groups (group II) on the 3rd and 7th day
compared to the nonischemic group (group I). Irkorucu et
al. [20] published that PMNL infiltration and necrosis were
higher in the ischemia-induced left colon anastomosis than
in the nonischemic group. These findings showed that the
inflammatory process was more intense in ischemic colon
anastomosis compared to nonischemic ones, and therefore
oxidative stress might be dominant as well.
Experimental studies indicated that CORM-2 reduces
cellular damage by reducing the duration and severity of
oxidative stress, suppressing MPO activity, and inhibiting
nuclear factor-κB (NF-κB), which increases the release of
proinflammatory cytokines [25,26]. Adach et al. [26] stated
that ROM (H2O2, H2O2/Fe) added to human plasma (in
vitro) increased oxidative stress and addition of CORM2 decreased lipid peroxidation. CORM-2 has been shown
to reduce TNF-α (tumor necrosis factor), intercellular
adhesion molecule 1 (ICAM-1), and E-selectin levels thus
reducing PMNL infiltration, relieving tissue edema, and
suppressing myeloperoxidase activity in small intestine
ischemia-reperfusion injury model in rats [12].
CORM-2 has been shown to reduce inflammatory
cell infiltration, tissue edema, and necrosis via the
same mechanisms [13]. In this study, we found that the
increased level of MDA in the tissue of the ischemia
group (group II) have been decreased following the
administration of CORM-2 (group III) on both the 3rd
and 7th day. However, we also found that increased PMNL
infiltration and edema in ischemic tissue did not decrease
with the administration of CORM-2. These results show
that CORM-2 suppresses cell damage and oxidative

Figure 3a. Microscopic appearance of the tissue on the 7th day in
Group I, partial neoangiogenesis (10x10, H&E).

Figure 3b. Microscopic appearance of the tissue on 7th day in
Group III, marked neoangiogenesis (20x10, H&E).
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process, although it does not reduce PMNL infiltration
caused by inflammation in ischemic anastomosis.
ROMs cause endothelial damage, causing occlusion of
vessels, and widening of necrosis [24]. Meng et al. [27]
have investigated lipopolysaccharide-stimulated human
umbilical vein endothelial culture and elaborated that
CORM-2 exhibited an antithrombotic effect by inhibiting
NF-κB and increasing thrombomodulin and endothelial
protein C receptor activity that protect endothelial cells
in the vascular endothelium. Magierowska et al. [28]
reported that local necrosis of the gastric mucosa that the
administration of CORM-2 resulted in increased tissue
blood flow and significant prevention of cell necrosis via its
antioxidative effect which was induced with 75% ethanol.
Similarly, in this study, the increased histological necrosis
on the 7th day of ischemia was reduced by 50% with the
administration of CORM-2. Although this result was not
statistically significant, the reduction of necrosis by half is
an important finding. These findings suggest that CORM-2
causes a decrease in cell necrosis by preventing thrombosis
of small vessels due to ischemia-related impaired blood
flow by vasodilation.
Studies have shown that CORM-2 reduces apoptosis
via caspase-3 inhibition and contributes to cell stability by
increasing heat shock protein production via p38 kinase
[29–31]. In this study, we observed that the antiapoptotic
effect of CORM-2 might have contributed to the reduction
of ischemia-induced necrosis.
In addition to its antioxidant function, glutathione
has been shown to play a role in modulation of signal
transduction, cell proliferation, and regulation of immune
response [32,33]. In the study of Sawle et al. [34] the
addition of CORM-2 to macrophage culture supplemented
with lipopolysaccharide led to the increase of glutathione,
which is a powerful antioxidant agent. Our results have
been correlated with these outcomes and we found that
administration of CORM-2 resulted in increase of the
glutathione that have been decreased due to ischemia on
the 7th day. These findings show that CORM-2 strengthens
the intracellular antioxidant system while suppressing
oxidative stress.
Neoangiogenesis is another physiological process that
is critical in the wound healing [35]. Vascular endothelial
growth factor (VEGF) is induced by hypoxia [36]. It can
act as an angiogenic coactivator known as the hypoxiainducible factor (HIF) [37]. HIF shows angiogenic effect
by downregulating transcriptional cofactor PGC1β,
which suppresses proangiogenic genes while inducing
antiangiogenic genes [37]. Choi et al. [38] showed
that addition of CORM-2 to the astrocyte cell culture
stimulates angiogenesis by increasing VEGF synthesis
and simultaneously increases the levels of heat shock
protein HSP90, thereby enhancing the stability of HIF-

1α and ensuring the continuation of the angiogenesis
process. Similarly, Ahanger et al. [13] found that CORM-2
increased neovascularization in full-thickness skin wound
model. In this study, we found that neoangiogenesis
tended to increase in the ischemic group (group II) on
the 7th day, compared to the nonischemic group (group
I), but this difference was not statistically significant.
We found that neoangiogenesis increased significantly
with the administration of CORM-2 (group III) to the
ischemic group compared to both the nonischemic (group
I) and ischemic group (group II). These findings suggest
that CORM-2 facilitates the cellular stability undergoing
ischemia to maintain their viability and that CORM-2
creates a synergistic effect with angiogenesis.
Experimental studies showed that CORM-2 decreases
intestinal epithelial damage due to inflammation and
increases epithelial development in a full-thickness
skin wound model [13,39]. In the experimental model
of Uchiyama et al. [40] CORM-2 increased epithelial
development by stimulating the synthesis of fibroblast
growth factor-15 (FGF-15) from myofibroblasts. Similarly,
in this study, we found that administration of CORM-2
increased the epithelial development that was diminished
due to ischemia on the 7th day. These findings along with
results from previous studies show that CORM-2 increases
epithelial development in GI anastomosis.
In the proliferative period, smooth muscle cells and
fibroblasts synthesize collagen, which forms the main
structure of tissue strength. In this period, the decrease
in collagen synthesis or increase in its degradation
significantly increases the risk for anastomotic leaks [3].
Anastomotic strength can be assessed by intraluminal
burst pressure measurement or by hydroxyproline, which
can quantitatively indicate collagen deposition in tissue
[3].
Similar to our outcomes, Irkorucu et al. [20] found that
the hydroxyproline level decreased in the ischemic colon
model. In this study, we found that hydroxyproline levels in
the ischemic group (group II), which was not treated with
CORM-2, was significantly lower than the nonischemic
group (group I). These findings show that ischemia
decreases collagen production in the GI anastomosis. In
the experimental study with a full-thickness skin wound
model, they found that the hydroxyproline level increased
significantly in the group treated with CORM-2 compared
to the group that was not [13]. Similarly, in our study,
the hydroxyproline levels were higher in the ischemic
group treated with CORM-2 (group III) compared to the
untreated ischemic group (group II). These findings show
that CORM-2 protects the cells involved in the synthesis of
collagen, which is the main force of anastomosis, against
oxidative stress in the inflammatory process and thus
enables continuous functioning of these cells.
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Previous studies have reported higher ABP in ischemic
colon anastomosis compared to the nonischemic group
[20]. In this study, the ABP was found to be significantly
lower in the ischemic group not treated with CORM-2
(group II), compared to the nonischemic group (group
I). We also elaborated that ABP tended to increase when
CORM-2 was administered to the ischemic group (group
III). However, this increase was not statistically significant.
These findings show that CORM-2 provides balance in
collagen synthesis and degradation and this balance may
cause an increase in the physical strength of anastomosis.
5. Conclusion
In this study, we found that CORM-2 increases the level
of antioxidant glutathione in the tissue, reduces the
level of MDA, which is an indicator of cell destruction,
and decreases the rate of necrosis histopathologically.

In addition to these protective effects, we observed that
CORM-2 increases tissue neovascularization, increases
the level of HP in the tissue, and supports epithelial
development. In the light of these findings, we think that
the use of CORM-2 may have positive effects on GIS
anastomosis healing.
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